Terms: = Lymphoma AND FBXW7, AGO, 55294, ENSG00000109670, FLJ11071, SEL-10, CDC4, FBXW6, SEL10, FBW7, DKFZp686F23254, FBX30 AND Clinical Outcome
7 results:
1. Aggressive B-cell lymphoma: chasing the target.
Walewski J
J Investig Med; 2020 Feb; 68(2):331-334. PubMed ID: 31672721
[TBL] [Abstract] [Full Text] [Related]
2. Improving therapeutic activity of anti-CD20 antibody therapy through immunomodulation in lymphoid malignancies.
Lipowska-Bhalla G; Fagnano E; Illidge TM; Cheadle EJ
Leuk Lymphoma; 2016; 57(6):1269-80. PubMed ID: 27050042
[TBL] [Abstract] [Full Text] [Related]
3. Chronic lymphocytic leukemia: a clinical review including Korean cohorts.
Jeon YW; Cho SG
Korean J Intern Med; 2016 May; 31(3):433-43. PubMed ID: 27044858
[TBL] [Abstract] [Full Text] [Related]
4. Inhibitors of the AAA+ chaperone p97.
Chapman E; Maksim N; de la Cruz F; La Clair JJ
Molecules; 2015 Feb; 20(2):3027-49. PubMed ID: 25685910
[TBL] [Abstract] [Full Text] [Related]
5. NOTCH1 and fbxw7 mutations favor better outcome in pediatric South Indian T-cell acute lymphoblastic leukemia.
Natarajan V; Bandapalli OR; Rajkumar T; Sagar TG; Karunakaran N
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e23-30. PubMed ID: 25493453
[TBL] [Abstract] [Full Text] [Related]
6. Resistance to apoptosis should not be taken as a hallmark of cancer.
Wang RA; Li ZS; Yan QG; Bian XW; Ding YQ; Du X; Sun BC; Sun YT; Zhang XH
Chin J Cancer; 2014 Feb; 33(2):47-50. PubMed ID: 24417874
[TBL] [Abstract] [Full Text] [Related]
7. Future of idiotypic vaccination for B-cell lymphoma.
de Cerio AL; Inogés S
Expert Rev Vaccines; 2009 Jan; 8(1):43-50. PubMed ID: 19093772
[TBL] [Abstract] [Full Text] [Related]
